proadifen has been researched along with bradykinin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harbison, RG; Ignarro, LJ; Kadowitz, PJ; Wood, KS | 1 |
| Berg, T; Holte, HR | 1 |
| Chiribiri, A; Gattullo, D; Pagliaro, P; Paolocci, N; Penna, C; Rastaldo, R | 1 |
| Boels, PJ; Deutsch, J; Gao, B; Haworth, SG | 1 |
| Hayashi, H; Katoh, H; Ohashi, K; Ozeki, M; Satoh, H; Takeuchi, K; Terada, H; Tran, QK; Uehara, A; Watanabe, H | 1 |
| Berges, A; Timmermans, JP; Van Nassauw, L; Vrints, C | 1 |
| Castro-Chaves, P; Fontes-Carvalho, R; Leite-Moreira, AF; Soares, S | 1 |
7 other study(ies) available for proadifen and bradykinin
| Article | Year |
|---|---|
Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
Topics: Acetylcholine; Animals; Arachidonic Acid; Arachidonic Acids; Atropine; Bradykinin; Cattle; Endothelium; Enzyme Activation; Guanylate Cyclase; Hemoglobins; In Vitro Techniques; Methylene Blue; Nitric Oxide; Proadifen; Pulmonary Artery; Pulmonary Veins; Quinacrine; Solubility; Vasodilator Agents | 1986 |
The role of nephrectomy and proadifen in blood pressure homeostasis following an acute kinin-induced hypotension in normotensive rats.
Topics: Animals; Arginine; Blood Pressure; Bradykinin; Enzyme Inhibitors; Homeostasis; Hypotension; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Proadifen; Rats; Rats, Wistar | 1996 |
Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Blood Pressure; Bradykinin; Coronary Vessels; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Enzyme Inhibitors; Heart; Heart Rate; In Vitro Techniques; Indomethacin; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Octoxynol; Proadifen; Rats; Rats, Wistar; Tachyphylaxis; Triazoles; Ventricular Function, Left | 2001 |
Perinatal development influences mechanisms of bradykinin-induced relaxations in pulmonary resistance and conduit arteries differently.
Topics: Acetylcholine; Analysis of Variance; Animals; Animals, Newborn; Bradykinin; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Proadifen; Pulmonary Artery; Substance P; Swine; Vascular Resistance; Vasodilator Agents | 2001 |
Effects of cytochrome P450 inhibitors on agonist-induced Ca2+ responses and production of NO and PGI2 in vascular endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antifungal Agents; Bradykinin; Calcium; Cyclic GMP; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Econazole; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Miconazole; Nitric Oxide; Proadifen; Prostaglandins I; Signal Transduction; Swine; Thapsigargin; Time Factors | 2003 |
Role of nitric oxide during coronary endothelial dysfunction after myocardial infarction.
Topics: Adenosine; Amidines; Animals; Benzylamines; Bradykinin; Coronary Circulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Heart; Immunohistochemistry; In Vitro Techniques; Male; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Proadifen; Rats; Rats, Wistar; RNA, Messenger; Superoxides | 2005 |
Negative inotropic effect of selective AT2 receptor stimulation and its modulation by the endocardial endothelium.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apamin; Bradykinin; Cardiovascular Agents; Charybdotoxin; Cyclooxygenase Inhibitors; Depression, Chemical; Dose-Response Relationship, Drug; Endocardium; Endothelial Cells; Enzyme Inhibitors; Hydroxocobalamin; Imidazoles; In Vitro Techniques; Indomethacin; Myocardial Contraction; Naphthyridines; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Papillary Muscles; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Proadifen; Pyridines; Rabbits; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Time Factors | 2008 |